-
Full Article (HTML) (53) -
Full Article (PDF) (14)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6815)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 28, 2016 (publication date) through Sep 30, 2020
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Number | Cited Articles |
| 1 |
Ahmed Swelam, René Adam, Lelde Lauka, Luiza Basilio Rodrigues, Sherif Elgarf, Mylène Sebagh, Nicolas Golse, Antonio Sa Cunha, Daniel Cherqui, Denis Castaing, Marc-Antoine Allard. A Model to Predict Significant Macrosteatosis in Hepatic Grafts. World Journal of Surgery 2020; 44(4): 1270 doi: 10.1007/s00268-019-05330-2
|
| 2 |
Yue-Yan Hu, Ning-Ling Dong, Qiu Qu, Xu-Fan Zhao, Hong-Ju Yang. The correlation between controlled attenuation parameter and metabolic syndrome and its components in middle-aged and elderly nonalcoholic fatty liver disease patients. Medicine 2018; 97(43): e12931 doi: 10.1097/MD.0000000000012931
|
| 3 |
Nobuharu Tamaki, Yohei Koizumi, Masashi Hirooka, Norihisa Yada, Hitomi Takada, Osamu Nakashima, Masatoshi Kudo, Yoichi Hiasa, Namiki Izumi. Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement method. Hepatology Research 2018; 48(10): 821 doi: 10.1111/hepr.13179
|
| 4 |
Cátia Arieira, Sara Monteiro, Sofia Xavier, Francisca Dias de Castro, Joana Magalhães, Carla Marinho, Rui Pinto, Washington Costa, José Pinto Correia, José Cotter. Transient elastography: should XL probe be used in all overweight patients?. Scandinavian Journal of Gastroenterology 2019; 54(8): 1022 doi: 10.1080/00365521.2019.1644367
|
| 5 |
Bei Gao, Atoosa Emami, Rongrong Zhou, Sonja Lang, Yi Duan, Yanhan Wang, Lu Jiang, Rohit Loomba, David A. Brenner, Peter Stärkel, Bernd Schnabl. Functional Microbial Responses to Alcohol Abstinence in Patients With Alcohol Use Disorder. Frontiers in Physiology 2020; 11 doi: 10.3389/fphys.2020.00370
|
| 6 |
Lea Ladegaard Grønkjær, Charlotte Wernberg, Mette Munk Lauridsen. Non-alcoholic fatty liver disease: the role of the nurse. Gastrointestinal Nursing 2020; 18(Sup6): S15 doi: 10.12968/gasn.2020.18.Sup6.S15
|
| 7 |
Lucija Ruzman, Ivana Mikolasevic, Kristina Baraba Dekanic, Sandra Milic, Goran Palcevski. Advances in diagnosis of chronic liver diseases in pediatric patients. World Journal of Pediatrics 2018; 14(6): 541 doi: 10.1007/s12519-018-0197-8
|
| 8 |
Lili Niu, Philipp E Geyer, Nicolai J Wewer Albrechtsen, Lise L Gluud, Alberto Santos, Sophia Doll, Peter V Treit, Jens J Holst, Filip K Knop, Tina Vilsbøll, Anders Junker, Stephan Sachs, Kerstin Stemmer, Timo D Müller, Matthias H Tschöp, Susanna M Hofmann, Matthias Mann. Plasma proteome profiling discovers novel proteins associated with non‐alcoholic fatty liver disease. Molecular Systems Biology 2019; 15(3) doi: 10.15252/msb.20188793
|
| 9 |
Ying-Hsiu Lin, Yung-Liang Wan, Dar-In Tai, Jeng-Hwei Tseng, Chiao-Yin Wang, Yu-Wei Tsai, Yi-Ru Lin, Tu-Yung Chang, Po-Hsiang Tsui. Considerations of Ultrasound Scanning Approaches in Non-alcoholic Fatty Liver Disease Assessment through Acoustic Structure Quantification. Ultrasound in Medicine & Biology 2019; 45(8): 1955 doi: 10.1016/j.ultrasmedbio.2019.04.018
|
| 10 |
Valerio Nobili, Anna Alisi, Luca Valenti, Luca Miele, Ariel E. Feldstein, Naim Alkhouri. NAFLD in children: new genes, new diagnostic modalities and new drugs. Nature Reviews Gastroenterology & Hepatology 2019; 16(9): 517 doi: 10.1038/s41575-019-0169-z
|
| 11 |
Haruka Hirono, Kazuhiko Watanabe, Katsuhiko Hasegawa, Shogo Ohkoshi. Practical Use of Transient Elastography in Screening for Nonalcoholic Steatohepatitis in a Japanese Population. Journal of Clinical and Translational Hepatology 2019; 7(2): 1 doi: 10.14218/JCTH.2018.00048
|
| 12 |
Cátia Arieira, Sara Monteiro, Sofia Xavier, Francisca Dias de Castro, Joana Magalhães, Maria J. Moreira, Carla Marinho, José Cotter. Hepatic steatosis and patients with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2019; 31(8): 998 doi: 10.1097/MEG.0000000000001319
|
| 13 |
Qiang Zeng, Zhenya Song, Yi Zhao, Jianjun Wu, Liuhong Wang, Huiyi Ye, Yingwei Wang, Ting Wu, Sishu Yuan, Haojie Yuan. Controlled attenuation parameter by vibration‐controlled transient elastography for steatosis assessment in members of the public undergoing regular health checkups with reference to magnetic resonance imaging‐based proton density fat fraction. Hepatology Research 2020; 50(5): 578 doi: 10.1111/hepr.13481
|
| 14 |
Fernando Barros, Ana Beatriz Monteiro Fonseca. Bariatric surgery during the evolution of fatty liver–A randomized clinical trial comparing gastric bypass and sleeve gastrectomy based on transient elastography. Clinical Obesity 2020; doi: 10.1111/cob.12393
|
| 15 |
M. Vanessa Bullón-Vela, Itziar Abete, J. Alfredo Martínez, M. Angeles Zulet. Obesity. 2018; : 111 doi: 10.1016/B978-0-12-812504-5.00006-4
|
| 16 |
Jelte J. Schaapman, Maarten E. Tushuizen, Minneke J. Coenraad, Hildo J. Lamb. Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease. Journal of Magnetic Resonance Imaging 2020; doi: 10.1002/jmri.27292
|
| 17 |
Bisher Sawaf, Adel Hajj Ali, Rola F. Jaafar, Mariam Kanso, Deborah Mukherji, Mohamad J. Khalife, Walid Faraj. Spectrum of liver diseases in patients referred for Fibroscan: A single center experience in the Middle East. Annals of Medicine and Surgery 2020; 57: 166 doi: 10.1016/j.amsu.2020.07.040
|
| 18 |
Chetan Mandelia, Mohammad Nasser Kabbany, Praveen Kumar Conjeevaram Selvakumar, Naim Alkhouri. The search for noninvasive methods to identify liver fibrosis in children with nonalcoholic fatty liver disease. Biomarkers in Medicine 2018; 12(3): 265 doi: 10.2217/bmm-2017-0038
|
| 19 |
Elena N. Shirokova, Chavdar S. Pavlov, Anna D. Karaseva, Aliya M. Alieva, Alla V. Sedova, Vladimir T. Ivashkin. Elastography in the Diagnosis of Non-Alcoholic Fatty Liver Disease. Annals of the Russian academy of medical sciences 2019; 74(1): 5 doi: 10.15690/vramn1071
|
| 20 |
Paula Cenira Senger de CASTRO, Helen Caroline Perussolo ALBERTON, Maria Lucia Alves PEDROSO, Daphne Benatti Gonçalves MORSOLETTO, Alcindo PISSAIA JUNIOR, Cláudia Alexandra Pontes IVANTES. EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARS. Arquivos de Gastroenterologia 2019; 56(3): 256 doi: 10.1590/s0004-2803.201900000-48
|
| 21 |
I. Mikolasevic, V. Lukenda Zanko, I. Jakopcic, V. Domislovic, A. Mijic, T. Stevanovic, B. Delija, T. Bokun, P. Dinjar Kujundzic, A. Ostojic, T. Filipec Kanizaj, I. Grgurevic, Z. Krznaric, D. Stimac, G. Targher. Prospective evaluation of non-alcoholic fatty liver disease by elastographic methods of liver steatosis and fibrosis; controlled attenuation parameter and liver stiffness measurements. Journal of Diabetes and its Complications 2020; 34(3): 107512 doi: 10.1016/j.jdiacomp.2019.107512
|
| 22 |
Xinrong Zhang, Grace Lai-Hung Wong, Vincent Wai-Sun Wong. Application of transient elastography in nonalcoholic fatty liver disease. Clinical and Molecular Hepatology 2020; 26(2): 128 doi: 10.3350/cmh.2019.0001n
|
| 23 |
Kyungsun Han, Ojin Kwon, Hyo-ju Park, So-Young Jung, Changsop Yang, Chang-Gue Son. Effect of Daesiho-tang on obesity with non-alcoholic fatty liver disease: a study protocol for a randomised, double-blind, placebo-controlled pilot trial. Trials 2020; 21(1) doi: 10.1186/s13063-020-4068-y
|
| 24 |
Ying-Hsiu Lin, Yin-Yin Liao, Chih-Kuang Yeh, Kuen-Cheh Yang, Po-Hsiang Tsui. Ultrasound Entropy Imaging of Nonalcoholic Fatty Liver Disease: Association with Metabolic Syndrome. Entropy 2018; 20(12): 893 doi: 10.3390/e20120893
|
| 25 |
Rishi Philip Mathew, Sudhakar Kundapur Venkatesh. Imaging of Hepatic Fibrosis. Current Gastroenterology Reports 2018; 20(10) doi: 10.1007/s11894-018-0652-7
|
| 26 |
FaisalA Alsaif, SaraH Alqahtani, AmaniM Alsadoon, KhalidA Alswat, AymanA Abdo, MazenM Hassanain, AbdulsalamB Alsharabi, GhadeerR Aljuhani, HishamM Alkhalidi, MohammadS Elsharkawy, MaramA Alotaibi, FaisalM Sanai, WaleedK Al-hamoudi. Prevalence of biopsy-proven nonalcoholic fatty liver among patients with gallstone disease. Saudi Journal of Gastroenterology 2020; 26(4): 204 doi: 10.4103/sjg.SJG_29_20
|
| 27 |
Ivana Mikolasevic, Andela Lukic, Toni Juric, Mia Klapan, Petra Madzar, Nikola Krolo, Doris Kolovrat, Ivanka Jurica, Iva Kedmenec, Domagoj Kihas, Doris Ilovaca, Ivan Erstic, Vanda Haralovic, Danijel Cavlina, Ema Dejhalla, Danijela Erdeljac, Benjamin Vukalovic, Nadija Skenderevic, Sandra Milic. Non-alcoholic fatty liver disease and transient elastography. Exploration of Medicine 2020; 1(4): 205 doi: 10.37349/emed.2020.00014
|
| 28 |
Leila Kamali, Atoosa Adibi, Shadi Ebrahimian, Fahime Jafari, Mohsen Sharifi. Diagnostic Performance of Ultrasonography in Detecting Fatty Liver Disease in Comparison with Fibroscan in People Suspected of Fatty Liver. Advanced Biomedical Research 2019; 8(1): 69 doi: 10.4103/abr.abr_114_19
|
| 29 |
Joshua Trowell, Joseph Alukal, Talan Zhang, Li Liu, Anurag Maheshwari, Hwan Y. Yoo, Paul J. Thuluvath. How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis?. Digestive Diseases and Sciences 2020; doi: 10.1007/s10620-020-06269-4
|
| 30 |
Tilman Kühn, Tobias Nonnenmacher, Disorn Sookthai, Ruth Schübel, Daniel Antonio Quintana Pacheco, Oyunbileg von Stackelberg, Mirja E. Graf, Theron Johnson, Christopher L. Schlett, Romy Kirsten, Cornelia M. Ulrich, Rudolf Kaaks, Hans-Ulrich Kauczor, Johanna Nattenmüller. Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0840-9
|
| 31 |
Rohit Loomba, Anjali Jain, Anna Mae Diehl, Cynthia D. Guy, Dana Portenier, Ranjan Sudan, Seema Singh, Claire Faulkner, Lisa Richards, Kelly D. Hester, Lauren Okada, Xiao-jun Li, Larry Mimms, Manal F. Abdelmalek. Validation of Serum Test for Advanced Liver Fibrosis in Patients With Nonalcoholic Steatohepatitis. Clinical Gastroenterology and Hepatology 2019; 17(9): 1867 doi: 10.1016/j.cgh.2018.11.004
|
| 32 |
Elham Ehrampoush, Alireza Ghaemi, Saeed Osati, Maryam Maleki, Hadi Raeisi Shahraki, Behnam Honarvar, Maryam Bahmanyar, Reza Homayounfar. The Association Between Serum Vitamin D Level and Nonalcoholic Fatty Liver Disease. Hepatitis Monthly 2019; 19(9) doi: 10.5812/hepatmon.92992
|
| 33 |
Young-Kyu Kim, Oh-Sung Kwon, Kyu Hee Her. The grade of nonalcoholic fatty liver disease is an independent risk factor for gallstone disease. Medicine 2019; 98(27): e16018 doi: 10.1097/MD.0000000000016018
|
| 34 |
Anna E. Ferguson, Stavra A. Xanthakos, Robert M. Siegel. Challenges in Screening for Pediatric Nonalcoholic Fatty Liver Disease. Clinical Pediatrics 2018; 57(5): 558 doi: 10.1177/0009922817733300
|
| 35 |
Gabriela Handzlik, Michał Holecki, Joanna Kozaczka, Michał Kukla, Katarzyna Wyskida, Leszek Kędzierski, Krzysztof Pawlicki, Jan Duława. Evaluation of metformin therapy using controlled attenuation parameter and transient elastography in patients with non-alcoholic fatty liver disease. Pharmacological Reports 2019; 71(2): 183 doi: 10.1016/j.pharep.2018.10.013
|
| 36 |
Ivana Mikolasevic, Sandra Milic, Tajana Filipec-Kanizaj. Fatty liver allografts are associated with primary graft non-function and high mortality after transplantation. Liver International 2017; 37(8): 1113 doi: 10.1111/liv.13453
|
| 37 |
Qun-Yan Yao, Ya-Dong Feng, Pei Han, Feng Yang, Guang-Qi Song. Hepatic microenvironment underlies fibrosis in chronic hepatitis B patients. World Journal of Gastroenterology 2020; 26(27): 3917-3928 doi: 10.3748/wjg.v26.i27.3917
|
| 38 |
Antonella Mosca, Nadia Panera, Annalisa Crudele, Anna Alisi. Noninvasive diagnostic tools for pediatric NAFLD: where are we now?. Expert Review of Gastroenterology & Hepatology 2020; : 1 doi: 10.1080/17474124.2020.1801413
|
| 39 |
Min-Sun Kwak, Goh Eun Chung, Jong In Yang, Jeong Yoon Yim, Su Jin Chung, Se Young Jung, Joo Sung Kim. Clinical implications of controlled attenuation parameter in a health check-up cohort. Liver International 2018; 38(5): 915 doi: 10.1111/liv.13558
|
| 40 |
Paul Manka, Amos Zeller, Wing-Kin Syn. Fibrosis in Chronic Liver Disease: An Update on Diagnostic and Treatment Modalities. Drugs 2019; 79(9): 903 doi: 10.1007/s40265-019-01126-9
|
| 41 |
Nicolás Salva-Pastor, Norberto C. Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease. The Journal of Steroid Biochemistry and Molecular Biology 2019; 194: 105445 doi: 10.1016/j.jsbmb.2019.105445
|
| 42 |
Eugenia Tsai, Tai-Ping Lee. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography. Clinics in Liver Disease 2018; 22(1): 73 doi: 10.1016/j.cld.2017.08.004
|
| 43 |
Mazen Noureddin, Micaela M Wong, Tsuyoshi Todo, Shelly C Lu, Arun J Sanyal, Edward A Mena. Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals. World Journal of Gastroenterology 2018; 24(11): 1269-1277 doi: 10.3748/wjg.v24.i11.1269
|
| 44 |
Paul A. Gomez, Kelly M. Zucker, Jean Chang, Michael W. Rowley, Anil B. Seetharam. Severe pretreatment hepatic steatosis influences response to direct acting antiviral therapy for chronic hepatitis C in a real world setting. Clinics and Research in Hepatology and Gastroenterology 2020; 44(2): e35 doi: 10.1016/j.clinre.2019.05.004
|
| 45 |
Aki Juhani Käräjämäki, Janne Hukkanen, Olavi Ukkola. The association of non-alcoholic fatty liver disease and atrial fibrillation: a review. Annals of Medicine 2018; 50(5): 371 doi: 10.1080/07853890.2018.1492147
|
| 46 |
Antonella Mirizzi, Isabella Franco, Carla Maria Leone, Caterina Bonfiglio, Raffaele Cozzolongo, Maria Notarnicola, Vito Giannuzzi, Valeria Tutino, Valentina De Nunzio, Irene Bruno, Claudia Buongiorno, Angelo Campanella, Valentina Deflorio, Annamaria Pascale, Filippo Procino, Paolo Sorino, Alberto Rubén Osella. Effects of Some Food Components on Non-Alcoholic Fatty Liver Disease Severity: Results from a Cross-Sectional Study. Nutrients 2019; 11(11): 2744 doi: 10.3390/nu11112744
|
| 47 |
Maneerat Chayanupatkul, Divya B. Dasani, Kristian Sogaard, Thomas D. Schiano. The Utility of Assessing Liver Allograft Fibrosis and Steatosis Post–Liver Transplantation Using Transient Elastography With Controlled Attenuation Parameter. Transplantation Proceedings 2020; doi: 10.1016/j.transproceed.2020.02.160
|
| 48 |
Zahra Dehnavi, Farkhonde Razmpour, Mahmoud Belghaisi Naseri, Mohsen Nematy, Seyed Ali Alamdaran, Hassan Ali Vatanparast, Mohsen Azimi Nezhad, Bita Abbasi, Azita Ganji. Fatty Liver Index (FLI) in Predicting Non-alcoholic Fatty Liver Disease (NAFLD). Hepatitis Monthly 2018; 18(2) doi: 10.5812/hepatmon.63227
|
| 49 |
Hong-Bae Kim, Yong-Jae Lee. Association of resting heart rate with nonalcoholic fatty liver disease in postmenopausal women. Medicine 2020; 99(14): e19529 doi: 10.1097/MD.0000000000019529
|
| 50 |
Ralf Weiskirchen, Frank Tacke. The Role of Radiologic Modalities in Diagnosing Nonalcoholic Steatohepatitis (NASH) and Fibrosis. Current Hepatology Reports 2018; 17(4): 324 doi: 10.1007/s11901-018-0421-y
|
| 51 |
Jianghua Zhou, Feng Zhou, Wenxin Wang, Xiao‐Jing Zhang, Yan‐Xiao Ji, Peng Zhang, Zhi‐Gang She, Lihua Zhu, Jingjing Cai, Hongliang Li. Epidemiological Features of NAFLD From 1999 to 2018 in China. Hepatology 2020; 71(5): 1851 doi: 10.1002/hep.31150
|
| 52 |
Somaya Albhaisi, Abhijit Chowdhury, Arun J. Sanyal. Non-alcoholic fatty liver disease in lean individuals. JHEP Reports 2019; 1(4): 329 doi: 10.1016/j.jhepr.2019.08.002
|
| 53 |
Chiara Pisetta, Claudia Chillè, Giovanni Pelizzari, Marie Graciella Pigozzi, Massimo Salvetti, Anna Paini, Maria Lorenza Muiesan, Carolina De Ciuceis, Chiara Ricci, Damiano Rizzoni. Evaluation of Cardiovascular Risk in Patient with Primary Non-alcoholic Fatty Liver Disease. High Blood Pressure & Cardiovascular Prevention 2020; 27(4): 321 doi: 10.1007/s40292-020-00389-8
|
| 54 |
Monica Lupsor-Platon. Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment. 2018; doi: 10.5772/intechopen.71161
|
| 55 |
Thomas G. Cotter, Mary Rinella. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease. Gastroenterology 2020; 158(7): 1851 doi: 10.1053/j.gastro.2020.01.052
|
| 56 |
Tavitiya Sudjaritruk, Torsak Bunupuradah, Linda Aurpibul, Pope Kosalaraksa, Nia Kurniati, Jiratchaya Sophonphan, Panruethai Trinavarat, Pannee Visrutaratna, Jiraporn Srinakarin, Nataruks Chaijitraruch, Thanyawee Puthanakit, Wing-Kin Syn. Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy. PLOS ONE 2019; 14(12): e0226375 doi: 10.1371/journal.pone.0226375
|
| 57 |
A. Mantovani, T. Turino, M.G. Lando, K. Gjini, C.D. Byrne, C. Zusi, F. Ravaioli, A. Colecchia, C. Maffeis, G. Salvagno, G. Lippi, E. Bonora, G. Targher. Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes. Diabetes & Metabolism 2020; 46(4): 296 doi: 10.1016/j.diabet.2019.11.004
|
| 58 |
You-Wen Tan, Xing-Bei Zhou, Yun Ye, Cong He, Guo-Hong Ge. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase. World Journal of Gastroenterology 2017; 23(31): 5746-5754 doi: 10.3748/wjg.v23.i31.5746
|
| 59 |
Mireen Friedrich-Rust, Fabian Schoelzel, Sebastian Maier, Florian Seeger, Julia Rey, Stephan Fichtlscherer, Eva Herrmann, Stefan Zeuzem, Joerg Bojunga, Pavel Strnad. Severity of coronary artery disease is associated with non-alcoholic fatty liver dis-ease: A single-blinded prospective mono-center study. PLOS ONE 2017; 12(10): e0186720 doi: 10.1371/journal.pone.0186720
|
| 60 |
Katharina Staufer, Mirko Dengler, Heidemarie Huber, Rodrig Marculescu, Rudolf Stauber, Carolin Lackner, Hans-Peter Dienes, Danijel Kivaranovic, Christian Schachner, Markus Zeitlinger, Beatrix Wulkersdorfer, Peter Rauch, Gerhard Prager, Michael Trauner, Wolfgang Mikulits. The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis. Cell Death & Disease 2017; 8(10): e3135 doi: 10.1038/cddis.2017.554
|
| 61 |
Tülay Çevik Saldiran, Fatma Karantay Mutluay, İlker Yağci, Yusuf Yilmaz. Impact of aerobic training with and without whole-body vibration training on metabolic features and quality of life in non-alcoholic fatty liver disease patients. Annales d'Endocrinologie 2020; doi: 10.1016/j.ando.2020.05.003
|
| 62 |
Sumitro Kosasih, Wong Zhi Qin, Rafiz Abdul Rani, Nazefah Abd Hamid, Ngiu Chai Soon, Shamsul Azhar Shah, Yazmin Yaakob, Raja Affendi Raja Ali. Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease. International Journal of Hepatology 2018; 2018: 1 doi: 10.1155/2018/9252536
|
| 63 |
Zeinab Anwar Elkabany, Rasha Tarif Hamza, Eman Abdel Rahman Ismail, Aisha Elsharkawy, Ayman Yosry, Sherief Musa, Marwa Ahmad Khalaf, Roba Maher Elgawesh, Gamal Esmat. Serum visfatin level as a noninvasive marker for nonalcoholic fatty liver disease in children and adolescents with obesity: relation to transient elastography with controlled attenuation parameter. European Journal of Gastroenterology & Hepatology 2020; 32(8): 1008 doi: 10.1097/MEG.0000000000001608
|
| 64 |
Nicha Teeratorn, Panida Piyachaturawat, Kessarin Thanapirom, Roongruedee Chaiteerakij, Kanokwan Sonsiri, Piyawat Komolmit, Pisit Tangkijvanich, Rungsun Rerknimitr, Leon Adams, Sombat Treeprasertsuk. Screening for non‐alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter‐transient elastography. JGH Open 2020; 4(2): 245 doi: 10.1002/jgh3.12252
|
| 65 |
Dae Ho Lee. Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease. Endocrinology and Metabolism 2020; 35(2): 243 doi: 10.3803/EnM.2020.35.2.243
|
| 66 |
Kanako Kato, Kunihiro Suzuki, Chie Aoki, Masaaki Sagara, Takafumi Niitani, Sho Wakamatsu, Kazunori Yanagi, Yoshimasa Aso. The effects of intermittent use of the SGLT-2 inhibitor, dapagliflozin, in overweight patients with type 2 diabetes in Japan: a randomized, crossover, controlled clinical trial. Expert Opinion on Pharmacotherapy 2017; 18(8): 743 doi: 10.1080/14656566.2017.1317748
|
| 67 |
Yuan Li, Shousheng Liu, Yuqiang Gao, Huan Ma, Shuhui Zhan, Yan Yang, Yongning Xin, Shiying Xuan. Association of TM6SF2 rs58542926 gene polymorphism with the risk of non-alcoholic fatty liver disease and colorectal adenoma in Chinese Han population. BMC Biochemistry 2019; 20(1) doi: 10.1186/s12858-019-0106-3
|
| 68 |
PreyaJanubhai Patel, Fabrina Hossain, Leigh Ula Horsfall, Xuan Banh, Kelly Lee Hayward, Suzanne Williams, Tracey Johnson, Anne Bernard, Nigel Neil Brown, Guy Lampe, Lyndall Buck, Nivene Saad, Anthony William Russell, Patricia Casarolli Valery, Katharine Margaret Irvine, Andrew Donald Clouston, Katherine Anne Stuart, William Rosenberg, Elizabeth Ellen Powell. A Pragmatic Approach Identifies a High Rate of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Diabetes Clinics and At‐Risk Populations in Primary Care. Hepatology Communications 2018; 2(8): 897 doi: 10.1002/hep4.1208
|